Kanada - Englisch - Health Canada

fresenius kabi canada ltd - caspofungin (caspofungin acetate) - powder for solution - 70mg - caspofungin (caspofungin acetate) 70mg - echinocandins

Malta - Englisch - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Malta - Englisch - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - caspofungin -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - caspofungin -

Irland - Englisch - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - caspofungin acetate - powder for concentrate for solution for infusion - 50 milligram(s) - caspofungin

Irland - Englisch - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - caspofungin acetate - powder for concentrate for solution for infusion - 70 milligram(s) - caspofungin

Malta - Englisch - Medicines Authority

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Malta - Englisch - Medicines Authority

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - caspodas is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.